Goshajinkigan
Specifically for Dry Eye Syndrome
0 up • 0 down
Why it works for Dry Eye Syndrome:
Neurotrophic/tear reflex pathway support. The only controlled human study relevant to dry-eye endpoints found that oral GJG improved corneal sensitivity and tear production (Schirmer’s test) and reduced fluorescein staining—changes that would be expected to relieve “neurotrophic” or neuropathy-related dry eye. The population was adults with type 1 diabetes and ocular surface disease (not general DED), but the mechanism (improving corneal nerve function → better reflex tearing and surface integrity) is directly relevant to many dry eye presentations that include decreased corneal sensitivity. Europe PMC
Plausible mechanistic underpinnings. The manufacturer’s pharmacology summary (based on preclinical and small clinical studies) describes κ-opioid/dynorphin–mediated antinociception, nitric-oxide–linked increases in peripheral blood flow, and modulation of sensory pathways—all mechanisms that could enhance ocular surface homeostasis if corneal neuropathy is present. tsumura.co.jp
How to use for Dry Eye Syndrome:
Dose used in studies / labeling: 7.5 g per day of standardized extract granules (TJ-107), usually 2–3 divided doses before or between meals. The diabetic ocular-surface RCT referenced above used 2.5 g three times daily for 3 months. tsumura.co.jp
Product/composition: TJ-107 is a 10-herb formula (rehmannia, achyranthes, cornus, dioscorea, plantago, alisma, poria, moutan, cinnamon, processed aconite). Use regulated products with known composition. tsumura.co.jp
Who it’s “for” in Kampo terms: Labeling emphasizes using it when the patient’s “SHO” (pattern/constitution) fits—practically, that means prescribing by a Kampo-trained clinician rather than self-selecting. tsumura.co.jp
Scientific Evidence for Dry Eye Syndrome:
Direct/near-direct evidence on ocular surface & tears
- Nagaki et al., 2003 (double-masked RCT, insulin-dependent diabetes) — Oral GJG vs control improved corneal sensitivity, Schirmer tear volume, and fluorescein staining after treatment. This is the most cited controlled clinical study linking GJG to tear production and ocular surface improvement. (American Journal of Chinese Medicine 31:103-109). Europe PMC
- The study is summarized in the Japan Society for Oriental Medicine’s Evidence Report with dosing details (2.5 g TID for ~3 months). jsom.or.jp
Supportive/indirect sources
- Review articles (ophthalmology/Kampo) mentioning improvement of ocular surface disorders with oral GJG in type 1 diabetes. These are narrative reviews rather than new trials, but they corroborate the above finding. Europe PMC
- Mechanistic/label pharmacology (human skin blood-flow changes; preclinical sensory-nerve effects) support a neurotrophic rationale but are not dry-eye trials. tsumura.co.jp
Specific Warnings for Dry Eye Syndrome:
(From the official Japanese package insert and pharmacovigilance summaries)
- Serious but rare risks reported: Interstitial pneumonia and hepatic dysfunction/jaundice—stop the drug and seek medical care if you develop cough/fever/shortness of breath or abnormal liver tests. tsumura.co.jp
- Pregnancy & lactation: Not recommended; some ingredients (Achyranthes root, Moutan bark; and the formula’s processed aconite) raise concerns for premature labor/abortion or maternal adverse reactions. tsumura.co.jp
- Elderly & children: Use cautiously and consider dose reduction in older adults; administer carefully in children. tsumura.co.jp
- Common adverse effects: GI upset (nausea, abdominal discomfort, diarrhea/constipation), palpitations, hot flush, tongue numbness, rash/itch—discontinue if these occur. tsumura.co.jp
- Aconite-related caution & interactions: GJG contains processed aconite—avoid combining with other aconite-containing remedies and stick to regulated products. tsumura.co.jp
- Very rare case reports: Drug-induced interstitial pneumonia has been described with GJG use. Drugs.com
- Use under clinician supervision: Labeling stresses prescribing per Kampo pattern (“SHO”), monitoring progress, and avoiding prolonged use if no benefit. tsumura.co.jp
General Information (All Ailments)
What It Is
Goshajinkigan (GJG) is a traditional Japanese Kampo formula derived from classical Chinese herbal medicine. It is composed of 10 natural herbs, including Rehmannia root, Achyranthes root, Cornus fruit, Alisma rhizome, Poria sclerotium, Moutan bark, Plantago seed, Cinnamon bark, Processed Aconite root, and Peony root.
It is commonly prescribed for symptoms associated with nerve pain, numbness, and coldness in the extremities, as well as polyuria (frequent urination), back pain, and leg weakness, especially in older adults. In modern clinical use, it has also been investigated for managing chemotherapy-induced peripheral neuropathy (CIPN) and diabetic neuropathy.
How It Works
Goshajinkigan is based on Kampo and Traditional Chinese Medicine (TCM) theories of balancing “Ki” (energy), “Ketsu” (blood), and “Sui” (fluids) within the body. Its pharmacological effects can be understood through both traditional and modern biomedical perspectives:
- Traditional Mechanism: GJG is believed to tonify the kidney and strengthen circulation, which in Kampo theory supports lower body function, relieves pain, and restores balance to the body’s energy systems. The inclusion of Aconite and Cinnamon promotes warmth and improves blood flow, addressing “cold” symptoms such as numbness and stiffness.
- Modern Pharmacological Insights: Research suggests that GJG works through several physiological pathways:
- Neuroprotective effects: It modulates nerve signaling and may enhance nitric oxide production, improving microcirculation in peripheral nerves.
- Antioxidant and anti-inflammatory actions: Certain herbal components reduce oxidative stress and suppress inflammation, both key factors in neuropathic pain.
- Analgesic effects: It may influence pain perception by regulating neurotransmitters and sensory neuron function.
- Renal and metabolic support: Some ingredients promote diuresis and aid in managing mild kidney-related metabolic imbalances.
Why It’s Important
Goshajinkigan holds clinical importance for several reasons:
- Adjunctive Use in Neuropathy: It has been widely studied and used in Japan for alleviating numbness, pain, and tingling associated with diabetic neuropathy and chemotherapy-induced peripheral neuropathy, especially from agents like oxaliplatin or paclitaxel. Some clinical trials report symptom relief and improved quality of life.
- Holistic Approach: Unlike conventional drugs that often target a single pathway, GJG works multifactorially, addressing circulation, nerve health, and energy balance simultaneously. This makes it attractive as a complementary therapy in chronic conditions where standard pharmacologic options may have limited efficacy.
- Cultural and Clinical Integration: Goshajinkigan is one of the Kampo formulations approved by Japan’s Ministry of Health, Labour and Welfare, meaning it’s recognized within the official healthcare system and often prescribed by physicians alongside modern medications.
Considerations
While Goshajinkigan is generally considered safe when used appropriately, several considerations are important:
Safety and Side Effects:
- Common side effects are rare but may include gastrointestinal upset, rash, or allergic reactions. Because it contains Aconite root, it should be prepared and dosed correctly — improper formulations can cause toxicity.
- In rare cases, hypokalemia (low potassium) or pseudoaldosteronism may occur, particularly in long-term use or in individuals sensitive to glycyrrhizin from licorice (if included in variant formulas).
Interactions:
- GJG may interact with diuretics, antihypertensive drugs, or other herbal supplements that affect electrolyte balance or blood pressure.
- It should be used with caution in patients with cardiovascular disease, kidney impairment, or hypertension.
Individual Suitability:
- Kampo medicine emphasizes individualized diagnosis — meaning Goshajinkigan is most effective for people exhibiting certain patterns, such as “kidney yang deficiency” (characterized by coldness, fatigue, and weak lower body). It is not suitable for people with heat-type or inflammatory conditions.
Clinical Evidence:
- While several Japanese studies and some international research support its benefits, results are mixed, and larger, well-controlled clinical trials are needed to fully establish its efficacy for neuropathy and other conditions.
Helps with these conditions
Goshajinkigan is most effective for general wellness support with emerging research . The effectiveness varies by condition based on clinical evidence and user experiences.
Detailed Information by Condition
Dry Eye Syndrome
Neurotrophic/tear reflex pathway support. The only controlled human study relevant to dry-eye endpoints found that oral GJG improved corneal sensitivi...
Community Discussion
Share results, tips, and questions about Goshajinkigan.
Loading discussion...
No comments yet. Be the first to start the conversation!
Discussion for Dry Eye Syndrome
Talk specifically about using Goshajinkigan for Dry Eye Syndrome.
Loading discussion...
No comments yet. Be the first to start the conversation!
Remedy Statistics
Helps With These Conditions
Recommended Products
No recommended products added yet.